Literature DB >> 15190081

Basic calcium phosphate crystals activate p44/42 MAPK signal transduction pathway via protein kinase Cmicro in human fibroblasts.

Paul M Reuben1, Yubo Sun, Herman S Cheung.   

Abstract

Although basic calcium phosphate (BCP) crystals are common in osteoarthritis, the crystal-induced signal transduction pathways in human fibroblasts have not been fully comprehended. We have previously demonstrated that the induction of matrix metalloproteinases (MMP) 1 and 3 by BCP crystals follows both the calcium-dependent protein kinase C (PKC) pathway and the calcium-independent p44/42 mitogen-activated protein kinase (p44/42 MAPK) pathway. Although we showed that the calcium-dependent PKC pathway was characterized by calcium-dependent PKCalpha, here we show that the calcium-independent p44/42 MAPK pathway is mediated by calcium-independent PKCmicro. Inhibition of PKCmicro synthesis and activity by antisense oligodeoxynucleotides and H-89 (N-(2-[p-bromocinnamylamino]ethyl)-5-isoquinolinesulfonamide), respectively, results in the inhibition of p44/42 MAPK activation, thus demonstrating that p44/42 MAPK activity is dependent upon PKCmicro. Reverse transcription-polymerase chain reaction and Western blotting also show that inhibition of PKCmicro results in the inhibition of MMP-1 and MMP-3 mRNA and protein expression as a result of p44/42 MAPK inhibition. These results now lead us to the conclusion that BCP crystal activation of human fibroblasts follows two pathways: 1) the calcium-dependent PKC pathway characterized by PKCalpha and 2) the calcium-independent p44/42 MAPK pathway mediated by PKCmicro, which operate independently leading to an increase in mitogenesis and MMP synthesis and ultimately complementing each other for the efficient regulation of cellular responses to BCP crystal stimulation of human fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15190081     DOI: 10.1074/jbc.M403406200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  The potential use of protein kinase D inhibitors for prevention/treatment of epidermal tumors.

Authors:  Senthil Nathan Arun; Ding Xie; M Ernest Dodd; Xiaofeng Zhong; Wendy B Bollag
Journal:  J Dermatol Sci       Date:  2010-08-10       Impact factor: 4.563

2.  Phosphorylation Regulates Functions of ZEB1 Transcription Factor.

Authors:  M Candelaria Llorens; Guadalupe Lorenzatti; Natalia L Cavallo; Maria V Vaglienti; Ana P Perrone; Anne L Carenbauer; Douglas S Darling; Ana M Cabanillas
Journal:  J Cell Physiol       Date:  2016-03-10       Impact factor: 6.384

3.  Basic calcium phosphate crystals activate c-fos expression through a Ras/ERK dependent signaling mechanism.

Authors:  Michael L Major; Herman S Cheung; Ravi P Misra
Journal:  Biochem Biophys Res Commun       Date:  2007-02-07       Impact factor: 3.575

4.  Point: Hydroxyapatite crystal deposition is intimately involved in the pathogenesis and progression of human osteoarthritis.

Authors:  Geraldine M McCarthy; Herman S Cheung
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

Review 5.  Counterpoint: Hydroxyapatite crystal deposition is not intimately involved in the pathogenesis and progression of human osteoarthritis.

Authors:  Kenneth P H Pritzker
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

6.  The role of Syk in osteoarthritis.

Authors:  Vasileios C Kyttaris
Journal:  Clin Immunol       Date:  2012-07-27       Impact factor: 3.969

7.  Sodium Thiosulfate Prevents Chondrocyte Mineralization and Reduces the Severity of Murine Osteoarthritis.

Authors:  Sonia Nasi; Hang-Korng Ea; Frédéric Lioté; Alexander So; Nathalie Busso
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

8.  Pyrophosphate Stimulates Differentiation, Matrix Gene Expression and Alkaline Phosphatase Activity in Osteoblasts.

Authors:  Michael Pujari-Palmer; Shiuli Pujari-Palmer; Xi Lu; Thomas Lind; Håkan Melhus; Thomas Engstrand; Marjam Karlsson-Ott; Hakan Engqvist
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.